The technology works. The challenge is what happens on the receiving end.
The platforms best equipped to handle that volume pair AI-assisted prioritization with review by a certified device specialist. This guide breaks down how each major platform stacks up.
A study published in JACC: Clinical Electrophysiology found that across a cohort of more than 26,000 patients with CIEDs, remote monitoring generated more than 82,000 alerts in a single year, highlighting the growing challenge of alert fatigue in device clinics.
Which platforms are actually built to handle that volume intelligently is what this guide is here to answer.
What Does Strong Alert Triage Actually Require?
Strong alert triage starts with one question: does the platform help your team act faster on what matters, or does it just deliver more data to sort through? The criteria below are what separate platforms built for clinical efficiency from those that simply relay transmissions.
Prioritization and Specialist Review Before Alerts Reach a Physician
The most effective platforms apply AI-assisted triage upstream and have a certified specialist review transmissions before they reach a physician, so noise and false positives are dealt with early. This matters more than most vendors acknowledge.
Research published in JACC: Clinical Electrophysiology found that ILR false positive rates ranged from 46% to 86% depending on the indication for implantation, meaning clinicians at practices without upstream triage are manually adjudicating transmissions that never needed their attention.
Acuity-Based Prioritization
Not every alert carries the same urgency, and a platform that delivers them uniformly forces your team to make that determination themselves, transmission by transmission. Strong triage tools arrive with that work already done, surfacing red alerts first and giving staff a clear, consistent queue in place of an undifferentiated inbox.
Single-Interface Workflow Integration
Most device clinics manage patients across multiple manufacturers.
A platform that requires staff to toggle between proprietary portals for Abbott, Medtronic, Boston Scientific, and Biotronik adds friction at exactly the wrong moment. Consolidated, single-interface access is a practical necessity for any high-volume practice.
Actionable Reporting Over Time
Trend visibility, documentation support, and performance reporting separate a genuine triage tool from a simple alert relay.
The best platforms give clinics the data they need to refine alert programming, identify high-burden device categories, and demonstrate outcomes over time.
How the Major Platforms Compare
Remote monitoring platforms fall into two distinct categories: manufacturer portals tied to a single device brand, and third-party aggregators built to consolidate data across all of them.
Manufacturer Platforms
Merlin.net (Abbott)
Merlin.net is one of the most widely adopted platforms in the field.
It offers reliable automatic transmissions, solid device compatibility across Abbott's CIED portfolio, and a report format clinicians generally find readable and consistent.
On triage, Merlin.net presents alerts as the device generates them, so separating actionable transmissions from noise is left to the clinic's own workflow.
For practices managing large ILR populations, that work adds up quickly.
Latitude NXT (Boston Scientific)
Latitude NXT brings some meaningful advantages, particularly its connectivity monitoring, which tracks whether patients are transmitting on schedule and flags gaps proactively.
On alert triage specifically, alerts are organized by device and transmission type, so a practice managing hundreds of patients will still need internal workflows to prioritize what gets reviewed first by clinical urgency.
CareLink (Medtronic)
CareLink is the platform most device clinic nurses have the most experience with, given Medtronic's market share in pacemakers and ILRs.
It offers detailed diagnostic data and a reporting structure that maps reasonably well to clinical documentation requirements. Alert burden is felt most here, given the size of Medtronic's ILR population.
In one study, false positive rates for Medtronic's earlier Reveal LINQ under nominal settings ranged from 46% to 86% across almost 700 transmissions in a four-week period. Newer LINQ II devices add AccuRhythm AI at the device level, and review of what reaches CareLink is still left to the clinic.
Biotronik Home Monitoring
Biotronik Home Monitoring is frequently cited for its daily automatic transmission capability, which gives clinicians a more continuous picture of patient status than platforms relying on scheduled or event-driven transmissions.
That cadence is a genuine clinical advantage for high-risk patients. The tradeoff is volume.
Daily transmissions across a sizable patient panel generate a substantial queue regardless of whether anything clinically meaningful has changed, and prioritizing that queue is left to the clinic.
Vendor-Neutral Platforms
Octagos
Octagos pairs Atlas AI™ with IBHRE-certified device specialists in what it calls the Two-Brain Approach™. Atlas AI™ prioritizes each transmission by clinical acuity, and a certified specialist reviews it before anything reaches a physician.
In a peer-reviewed study of 690,673 transmissions across 78 clinics, that approach reached 99.5% accuracy (JACC: Advances, 2025).
Bi-directional EHR integration is built in-house, deployment averages 20 days, and there is no charge for migration, integration, implementation or training. The OctaLink mobile app lets physicians review and e-sign from their phone.
Murj
Murj focuses on workflow automation and documentation for multi-vendor device clinics, and markets its reporting for research and quality-improvement work. Worth asking directly how alerts are prioritized and whether that method has published validation.
PaceMate
PaceMate markets an Auto-Triage engine that ranks patients across 14 device vendors to reduce alert fatigue, alongside a large aggregated dataset with pre-built dashboards.
Worth asking whether Auto-Triage performance has been published, and whether a certified clinician reviews alerts before they reach a physician.
Rhythm360
Rhythm360 markets automated billing capture and fast response times.
Worth asking how its alert triage works in practice and whether its performance has been published.
How Octagos Atlas AI Approaches Alert Triage
Most platforms solve part of the problem, such as consolidating manufacturer portals or ranking alerts to shorten the queue.
Fewer put a certified specialist's review on each alert before it reaches a physician.
That review is the core of how Octagos approaches triage. Atlas AI prioritizes each incoming transmission by clinical acuity, and in the Two-Brain Approach a certified cardiac device specialist reviews it before it reaches a physician's queue.
The result is a smaller, higher-confidence set of transmissions that actually warrant action.
That distinction matters in practice. Atlas AI prepares the read; the clinician makes the determination.
When a transmission sits in a gray zone, a certified device specialist reviewing it before escalation is what separates a missed event from an appropriate intervention. Octagos builds that review into the workflow by design.
The outcomes data supports the approach.
Results from Lehigh Valley Heart & Vascular Institute demonstrated meaningful reductions in non-actionable alert volume without an increase in missed clinical events, and peer-reviewed research in Heart Rhythm O2 reported a 57% reduction in non-actionable transmissions.
For high-volume practices and multi-health systems managing thousands of patients across multiple device types, that combination of AI prioritization and specialist review is what makes triage scalable without sacrificing accuracy.
Choosing the Right Tool for Your Practice
The right platform depends on where your practice is feeling the most pressure.
If your primary challenge is managing multiple manufacturer portals, any third-party aggregator will get you most of the way there.
Consolidated access alone reduces friction significantly for multi-vendor practices.
If alert volume and false positive burden are the core issue, the evaluation gets more specific. Automated triage helps, but the question worth asking any vendor is what happens when the triage engine is uncertain. A platform that escalates gray-zone transmissions directly to a physician without a clinical review step transfers that burden without resolving it.
For large cardiology practices and multi-health systems where transmission volume is high, staff bandwidth is constrained, and the cost of a missed event is significant, the combination of AI prioritization and specialist review is worth prioritizing.
A few questions worth bringing to any platform evaluation:
- What is the cost of the platform & integration fee? Pricing in cardiac remote monitoring varies significantly with some vendors charging heavy integration fees as well as per patient fees.
- What percentage of alerts reaching physicians are actionable? Vendors should have data on this. If they don't, that's informative.
- How are gray-zone transmissions handled? Confidence thresholds vary by vendor. Understanding what happens below that threshold tells you a lot about where staff burden accumulates.
- How does the platform handle cross-manufacturer data? Proprietary portals should be a dealbreaker for any practice managing devices from more than one manufacturer.
- What does implementation and ongoing support look like? A platform is only as effective as the team behind it. Clinical support and onboarding matter as much as the technology itself.
See How Atlas AI Handles Alert Triage
Alert triage is where remote monitoring programs win or lose clinical bandwidth.
If your practice is managing transmission volume across multiple manufacturers and your staff is still sorting every transmission by hand, it's worth seeing how a different approach works in practice.
Book a demo with Octagos to see how Atlas AI and the Two-Brain Approach reduce non-actionable alert volume and surface what actually needs clinical attention.